Keyphrases
Neuroblastoma
100%
Cell Lineage
100%
Tumor Cells
100%
T Cells
100%
Natural Killer Cells
100%
Immunogenicity
100%
MHC Class II
100%
Lineage Switch
100%
Epigenetic Modulation
100%
Histone Deacetylase Inhibitor (HDACi)
83%
Inhibitor of Apoptosis Proteins
66%
Neuroblastoma Cells
50%
Neuroblastoma Cell Line
50%
High-risk Neuroblastoma
50%
Organoids
33%
Patient-derived Organoids
33%
Surface Expression
33%
Entinostat
33%
Tumor-specific T Cells
33%
Natural Killer Cell Cytotoxicity
33%
Immune Response
16%
Healthy Donors
16%
Cytotoxic T Cells
16%
Transcriptome Analysis
16%
Adaptive Immune Response
16%
Adherent Cells
16%
Flow Cytometric Analysis
16%
Cytotoxic Activity
16%
In Vitro Effect
16%
Immuno
16%
Immune Regulation
16%
PRAME
16%
Pathway Activity
16%
Full Potential
16%
Modulating Effect
16%
High-throughput Flow Cytometry
16%
Drug Library Screening
16%
Drug Class
16%
Inhibiting Effect
16%
Immunomodulatory
16%
Immunomodulatory Activity
16%
Cell Donors
16%
Immunomodulatory Effect
16%
Drug Repurposing
16%
TAP1
16%
Inhibitor Drug
16%
Immunoproteasome Subunits
16%
T Cell Cytotoxicity
16%
Repurposing Strategy
16%
Nuclear factor-κB Pathway
16%
Translatome Analysis
16%
T-cell Immunogenicity
16%
Medicine and Dentistry
Ganglioneuroblastoma
100%
T Cell
100%
Tumor Cell
100%
Natural Killer Cell
100%
Immunogenicity
100%
Cell Lineage
100%
Major Histocompatibility Complex
75%
Histone Deacetylase Inhibitor
62%
Organoid
50%
Neuroblastoma Cell
37%
Neuroblastoma Cell Line
37%
Cytotoxicity
37%
In Vitro
25%
Immunotherapy
25%
Specific Tumor
25%
Entinostat
25%
Apoptosis Inhibitor
25%
Transcriptome
12%
Cytotoxic T-Cell
12%
Upregulation
12%
Flow Cytometry
12%
Cytokine
12%
Immunomodulation
12%
Immune Response
12%
Adherent Cell
12%
Drug Repositioning
12%
Immunity
12%
Immunoglobulin Enhancer Binding Protein
12%
Melanoma
12%
Immunology and Microbiology
T Cell
100%
Tumor Cell
100%
Natural Killer Cell
100%
Cell Lineage
100%
Immunogenicity
100%
Major Histocompatibility Complex
85%
Organoid
57%
Neuroblastoma Cell
42%
Cytotoxicity
42%
Neuroblastoma Cell Line
42%
Immunotherapy
28%
Transcriptome
14%
Cytotoxic T Cell
14%
Immune Response
14%
Upregulation
14%
Cytokine
14%
Adherent Cell
14%
Immunoglobulin Enhancer Binding Protein
14%
Immunity
14%
Immunomodulation
14%